|
Symbol Name ID |
Rfx5
regulatory factor X, 5 (influences HLA class II expression) MGI:1858421 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Rfx5tm1.1Ifo/Rfx5tm1.1Ifo involves: 129 * C57BL/6 |
abnormal B lymphocyte antigen presentation | J:67941 |
| abnormal dendritic cell morphology | J:67941 | |
| abnormal Kupffer cell morphology | J:67941 | |
| abnormal level of surface class II molecules | J:67941 | |
| abnormal MHC II cell surface expression on macrophages | J:67941 | |
| abnormal thymus cortex morphology | J:67941 | |
| decreased CD4-positive, alpha-beta T cell number | J:67941 | |
| decreased IgG1 level | J:67941 | |
| decreased IgM level | J:67941 | |
| decreased single-positive T cell number | J:67941 | |
| Rfx5tm1Ifo/Rfx5tm1.1Ifo Lyz2tm1(cre)Ifo/Lyz2+ involves: 129 * C57BL/6 * C.B-20 |
abnormal MHC II cell surface expression on macrophages | J:67924 |
| Rfx5tm1Ifo/Rfx5tm1Ifo involves: 129P2/OlaHsd * C57BL/6J |
normal immune system phenotype | J:282535 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||